Cargando…
Dihydroartemisinin attenuates lipopolysaccharide-induced acute lung injury in mice by suppressing NF-κB signaling in an Nrf2-dependent manner
Acute lung injury (ALI) is a severe health issue with significant morbidity and mortality. Artemisinin is used for the treatment of fever and malaria in clinical practice. Dihydroartemisinin (DHA), the major active metabolite of artemisinin, plays a role in anti-organizational fibrosis and anti-neur...
Autores principales: | Huang, Xiao-Ting, Liu, Wei, Zhou, Yong, Hao, Cai-Xia, Zhou, Yan, Zhang, Chen-Yu, Sun, Chen-Chen, Luo, Zi-Qiang, Tang, Si-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844637/ https://www.ncbi.nlm.nih.gov/pubmed/31661121 http://dx.doi.org/10.3892/ijmm.2019.4387 |
Ejemplares similares
-
Dihydroartemisinin attenuates lipopolysaccharide-induced osteoclastogenesis and bone loss via the mitochondria-dependent apoptosis pathway
por: Dou, C, et al.
Publicado: (2016) -
Dihydroartemisinin Attenuated Intervertebral Disc Degeneration via Inhibiting PI3K/AKT and NF-κB Signaling Pathways
por: Liao, Zhiheng, et al.
Publicado: (2022) -
Dihydroartemisinin attenuates autoimmune thyroiditis by inhibiting the CXCR3/PI3K/AKT/NF-κB signaling pathway
por: Liu, Huijuan, et al.
Publicado: (2017) -
Parthenolide attenuates LPS-induced activation of NF-κB in a time-dependent manner in rat myocardium()
por: Xie, Hong, et al.
Publicado: (2012) -
Rosiglitazone alleviates lipopolysaccharide-induced inflammation in RAW264.7 cells via inhibition of NF-κB and in a PPARγ-dependent manner
por: Zhou, Jing-Ping, et al.
Publicado: (2021)